Rare diseases
Investigational molecules
Locations
Back to Germany1 118 clinical trials in Sankt Augustin, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
GermanyA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
GermanyA study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B
GermanyStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
GermanyGlofitamab plus drug combination for relapsed/refractory large B‑cell lymphoma in high‑risk second‑line patients eligible for CAR‑T therapy
GermanyGermanyPhase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
GermanyRandomized trial of bupropion hydrochloride for fatigue in patients with long COVID (post‑COVID syndrome)
GermanyA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
GermanyA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
GermanyA study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
GermanyA study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for juvenile arthritis conditions, including studies of medications like baricitinib, ustekinumab, and bimekizumab for various forms of JIA.
Research aims to evaluate drug efficacy and safety in pediatric populations with autoimmune conditions.
Comprehensive studies on childhood cancers, with particular focus on leukemia and lymphoma treatments, including novel therapeutic approaches and combination therapies.
Investigations include targeted therapies and personalized treatment protocols for various cancer stages.
Specialized research into brain and nervous system tumors, focusing on ependymoma and medulloblastoma treatment strategies.
Studies evaluate surgical outcomes, radiation therapy approaches, and chemotherapy effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
